Medical Affairs is a critical scientific bridge between Healthcare companies and their internal & external stakeholders. It plays a leadership role in implementing cutting-edge medical, scientific, and patient-centered insights & solutions that drive strategy and innovation in healthcare. The healthcare ecosystem is dynamic and being transformed with the latest tech solutions. It is believed that […]Read More
Shots: BeiGene to commercialize Amgen’s Xgeva (denosumab), Kyprolis (carfilzomib) and Blincyto (blinatumomab) in China (Ex- Hong Kong, Macao & Taiwan) for 5 or 7yrs. with equal profit & loss sharing and will retain rights for one product plus will receive royalties on sales in China for an additional 5 yrs. on the products not retained […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
